Pathogenesis and treatment of enterococcal infections

Area of Science:

• Infectious Diseases
• Microbiology
• Pharmacology

Background:

• Enterococcal infections are a growing concern, particularly in healthcare settings.
• Urinary tract infections are a common source of enterococcal bacteremia and subsequent endocarditis.
• Increasing use of broad-spectrum antibiotics, especially cephalosporins, is linked to a rise in enterococcal infections.

Purpose of the Study:

• To review the pathogenesis and treatment of enterococcal infections.
• To highlight challenges in treating severe enterococcal infections like endocarditis and meningitis.
• To discuss antibiotic resistance patterns and treatment recommendations.

Main Methods:

• Literature review of pathogenesis and treatment of enterococcal infections.
• Analysis of antibiotic susceptibility and resistance trends.
• Evaluation of treatment outcomes for various enterococcal infections.

Main Results:

• Penicillin and vancomycin are not reliably bactericidal for enterococci, necessitating combination therapy for severe infections.
• Aminoglycoside synergy is crucial for treating endocarditis and meningitis, but resistance is increasing.
• Enterococci exhibit susceptibility to most penicillins, except antistaphylococcal agents; UTIs can often be treated with penicillin alone.
• Cephalosporins demonstrate minimal to no activity against enterococci.

Conclusions:

• Effective treatment of severe enterococcal infections (endocarditis, meningitis) requires a penicillin plus an aminoglycoside.
• Vancomycin with an aminoglycoside is an alternative for penicillin-allergic patients.
• Understanding enterococcal pathogenesis and resistance is critical for guiding appropriate antimicrobial therapy.